HERANTIS PHARMA - PHASE 1B BIOMARKER DATA SHOW CLEAR EVIDENCE OF BIOLOGICAL RESPONSE TO HER-096 IN PEOPLE WITH PARKINSON'S DISEASE

Reuters · 4d ago

Please log in to view news